TY - JOUR
T1 - Elucidation of Postfusion Structures of the Measles Virus F Protein for the Structure-Based Design of Fusion Inhibitors
AU - Takahara, Aoi
AU - Nakatsu, Toru
AU - Hirata, Kazushige
AU - Hayashi, Hironori
AU - Kawaji, Kumi
AU - Aoki, Keisuke
AU - Inuki, Shinsuke
AU - Ohno, Hiroaki
AU - Kato, Hiroaki
AU - Kodama, Eiichi
AU - Oishi, Shinya
N1 - Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025/2/13
Y1 - 2025/2/13
N2 - Measles is a highly infectious disease and remains a major cause of childhood mortality worldwide. In some cases, the measles virus (MV) induces subacute sclerosing panencephalitis within several years of the acute infection. The infection of the target cells by MV is mediated by the F protein, in which two heptad repeat regions, HR1 and HR2, form a six-helix bundle before membrane fusion. We previously reported anti-MV peptides, which were designed from the HR region of the MV F protein. Here, we characterized the essential interactions between the HR1 and HR2 regions on the postfusion six-helix bundles of synthetic HR1 and HR2 peptides by crystallographic studies. Based on the crystal structures, we identified the minimal α-helix sequence for antiviral activity. Additionally, optimizing HR2 peptides by introducing α-helix-inducible motifs and maintaining key hydrogen bond networks at the N- and C-terminal regions led to the identification of highly potent antiviral peptides.
AB - Measles is a highly infectious disease and remains a major cause of childhood mortality worldwide. In some cases, the measles virus (MV) induces subacute sclerosing panencephalitis within several years of the acute infection. The infection of the target cells by MV is mediated by the F protein, in which two heptad repeat regions, HR1 and HR2, form a six-helix bundle before membrane fusion. We previously reported anti-MV peptides, which were designed from the HR region of the MV F protein. Here, we characterized the essential interactions between the HR1 and HR2 regions on the postfusion six-helix bundles of synthetic HR1 and HR2 peptides by crystallographic studies. Based on the crystal structures, we identified the minimal α-helix sequence for antiviral activity. Additionally, optimizing HR2 peptides by introducing α-helix-inducible motifs and maintaining key hydrogen bond networks at the N- and C-terminal regions led to the identification of highly potent antiviral peptides.
UR - http://www.scopus.com/inward/record.url?scp=85216615596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216615596&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.4c02337
DO - 10.1021/acs.jmedchem.4c02337
M3 - Article
C2 - 39887040
AN - SCOPUS:85216615596
SN - 0022-2623
VL - 68
SP - 3123
EP - 3133
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 3
ER -